Although expression of HER family is reported to be down-regulated in artemisinin derivative treated breast cancer cells [36], expression of oncogene HER2 was amplified in artemisinin treated cells at both RNA and protein level but at the same time HER 1 protein expression was reduced significantly. This evidence concerns the gene ERBB2 and breast carcinoma.